Polysulfated Polysaccharides for Bone Marrow Edema Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current medical treatments for symptomatic bone marrow edema, such as rest, immobilization, NSAIDs, and corticosteroids, fail to address the underlying pathophysiology and can hinder natural tissue healing, while existing diagnostic methods like MRI lack optimal pulse signals for semi-quantification, complicating pain and joint function assessments.
Innovation Solution
Administration of polysulfated polysaccharides, specifically pentosan polysulfate, orally or systemically, to mammals with bone marrow edema, which reduces pain, diminishes lesion size, and attenuates TNF-α production, thereby addressing the underlying vascular and cellular changes causing pain.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments (rest, immobilization, NSAIDs, corticosteroids) are used for bone marrow edema, then pain management is attempted, but the underlying pathophysiology is not addressed and natural tissue healing is hindered
Solution Approach 1:
The patent uses polysulfated polysaccharides as an intermediary substance that mediates between the bone marrow edema and the healing process. These compounds act as a bridge to restore proteoglycan synthesis and inhibit catabolic enzymes, thereby facilitating natural healing without directly interfering with it like conventional treatments.
Solution Approach 2:
The invention changes the biochemical parameters of the bone marrow environment by introducing polysulfated polysaccharides that alter the balance between anabolic and catabolic processes. This shifts the tissue state from degradation to regeneration, addressing the root cause rather than just symptoms.
2Measurement precision
If MRI is used for diagnosis of bone marrow edema, then lesion detection is achieved, but optimal pulse signals for semi-quantification are lacking, complicating pain and joint function assessments
Solution Approach 1:
The patent replaces complex MRI signal processing requirements with a biochemical solution. Instead of relying on sophisticated imaging parameters and pulse sequences, the invention uses polysulfated polysaccharides whose effects can be measured through simpler biochemical markers of tissue healing and proteoglycan synthesis.
Data Source
AI summary
A method for the treatment of bone marrow edema in a mammal comprising administering an effective amount of a polysulfated polysaccharide including salts thereof, to a mammal in need of such treatment.